Dynavax Technologies Corporation [DVAX] stock for 232,146 USD was sold by Burgess Justin


Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Dynavax Technologies Corporation shares valued at $232,146 were sold by Burgess Justin on Feb 27. At $10.38 per share, Burgess Justin sold 22,371 shares. The insider’s holdings dropped to 0 shares worth approximately $0.0 following the completion of this transaction.

From Robots to Self-Driving Cars: 5 AI Stocks to Consider for Your Portfolio

The artificial intelligence (AI) revolution is already here and it's about to change everything we know about everything. With the global market for AI projected to grow from $137 billion in 2022 to over $1.81 trillion by 2030, there's never been a better time to invest in this burgeoning industry. That's why we've compiled a list of the Top 5 AI Stocks to Buy for 2023. These companies are at the forefront of the AI revolution, and have the potential to deliver huge returns to investors like you.

Get our free report, "Top 5 AI Stocks to Buy for 2023".


Also, Hack Andrew A. F. sold 1,500,000 shares, netting a total of over 17,400,000 in proceeds. Following the sale of shares at $11.60 each, the insider now holds 3,915,000 shares.

Before that, Novack David F had sold 52,204 shares from its account. In a trade valued at $650,984, the President & COO traded Dynavax Technologies Corporation shares for $12.47 each. Upon closing the transaction, the insider’s holdings decreased to 52,204 shares, worth approximately $21052.539999999997.

As published in their initiating research note from JMP Securities on September 27, 2022, Dynavax Technologies Corporation [DVAX] has been a Mkt outperform and the price target has been revised to $22. This represents a 53.68% premium over Wednesday’s closing price. As of August 06, 2021, Goldman has initiated its “Buy” rating for DVAX. Earlier on August 07, 2020, H.C. Wainwright resumed its rating. Their recommendation was “a Buy” for DVAX stock.

Analyzing DVAX Stock Performance

On Wednesday, Dynavax Technologies Corporation [NASDAQ: DVAX] plunged -1.07% to $10.19. The stock’s lowest price that day was $10.16, but it reached a high of $10.32 in the same session. During the last five days, there has been a drop of approximately -6.51%. Over the course of the year, Dynavax Technologies Corporation shares have dropped approximately -4.23%. Shares of the company reached a 52-week high of $12.02 on 02/03/23 and a 52-week low of $9.98 on 01/09/23. A 50-day SMA is recorded $11.07, while a 200-day SMA reached $11.94. Nevertheless, trading volume fell to 1.62 million shares from 2.02 million shares the previous day.

Support And Resistance Levels for Dynavax Technologies Corporation (DVAX)

According to the 24-hour chart, there is a support level at 10.13, which, if violated, would cause prices to drop to 10.06. In the upper region, resistance lies at 10.29. The next price resistance is at 10.38. RSI (Relative Strength Index) is 31.89 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.57, which suggests the price will decrease in the coming days. Percent R is at 94.78%, indicating bearish price movement. Stochastics %K at buying indicates that the stock is to be held.

Is Dynavax Technologies Corporation subject to short interest?

Stocks of Dynavax Technologies Corporation saw a sharp rise in short interest on Jan 30, 2023 jumping by 2.05 million shares to 14.85 million. Data from Yahoo Finance shows that the short interest on Dec 29, 2022 was 12.8 million shares. A jump of 13.8% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 11.09 of the overall float, the days-to-cover ratio (short ratio) jumped to 11.09.

Which companies own the most shares of Dynavax Technologies Corporation (DVAX)?

According to BlackRock Fund Advisors filings, the company currently owns 17,535,659 shares, which is about 13.74% of the total DVAX shares outstanding. The investor’s shares have appreciated by 643,438 from its previous 13-F filing of 16892221.0 shares. SSgA Funds Management, Inc. reduced a -2.74% interest valued at $113.71 million while The Vanguard Group, Inc. purchased a 177,725 stake. A total of 45,506 shares of Dynavax Technologies Corporation were bought by Chicago Capital LLC during the quarter, and -134,346 were sold by Fisher Asset Management LLC. In its current portfolio, PFM Health Sciences LP holds 3,805,370 shares valued at $43.31 million.

In terms of Dynavax Technologies Corporation share price expectations, FactSet research, analysts set an average price target of $23.17 in the next 12 months, up nearly 133.01% from the previous closing price of $10.30. Analysts anticipate Dynavax Technologies Corporation stock to reach $27.00 by 2023, with the lowest price target being $18.00. In spite of this, 6 analysts ranked Dynavax Technologies Corporation stock as a Buy at the end of 2023. On August 03, 2020, H.C. Wainwright assigned a price target of “a Buy” to the stock and reiterated coverage with a $14.


Please enter your comment!
Please enter your name here